Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Tumour-associated macrophages (TAMs) are enriched in glioblastoma multiformes (GBMs) that contain glioma stem cells (GSCs) at the apex of their cellular hierarchy. The correlation between TAM density and glioma grade suggests a supportive role for TAMs in tumour progression. Here we interrogated the molecular link between GSCs and TAM recruitment in GBMs and demonstrated that GSCs secrete periostin (POSTN) to recruit TAMs. TAM density correlates with POSTN levels in human GBMs. Silencing POSTN in GSCs markedly reduced TAM density, inhibited tumour growth, and increased survival of mice bearing GSC-derived xenografts. We found that TAMs in GBMs are not brain-resident microglia, but mainly monocyte-derived macrophages from peripheral blood. Disrupting POSTN specifically attenuated the tumour-supportive M2 type of TAMs in xenografts. POSTN recruits TAMs through the integrin αvβ₃ as blocking this signalling by an RGD peptide inhibited TAM recruitment. Our findings highlight the possibility of improving GBM treatment by targeting POSTN-mediated TAM recruitment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Periostin (Postn) is shown to be required for alternative (less inflammatory) activation of microglia in brain tumors (Zhou et al., 2015).”
From Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models (2018) · cites this paper as Zhou et al., 2015
Experimental — accuracy not yet measuredIn the citing paper
“TD2 genes were well characterized for regulation of phagocytosis and microglial activation (e.g. Lgasl3; Rotshenker, 2009), microglial survival (e.g. Spp1; Rabenstein et al., 2016), alternative M2 activation of microglia (Zhou et al., 2015), and lysosomal proton pump (Atp6v0d2).”
From Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models (2018) · cites this paper as Zhou et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C., Poppleton, H., Kocak, M., Hogg, T. L., Fuller, C., Hamner, B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,197
Crypt stem cells as the cells-of-origin of intestinal cancer
Barker, N., Ridgway, R. A., van Es, J. H., van de Wetering, M., Begthel, H., van den Born, M., Danenberg, E., Clarke, A. R., Sansom, O. J., & Clevers, H. (2009) · Nature · doi:10.1038/nature07602 · Cited by 2,166
Research works printed but not linked: 1
- Cheng L Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth Cell 153 139 152 2013 23540695 PMC3638263
Cited by
Items 101–200 of 942
Lin, S., Liao, Y.-C., Chen, P., Yang, Y., Wang, Y., Tung, S.-L., Chuang, C.-M., Sung, Y.-W., Jang, T., Chuang, S., et al. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00888-x · Cited by 167
“Our findings are consistent with the report that in a xenograft model POSTN secreted by glioblastoma stem cells was shown to help to recruit tumor-supportive TAMs via integrin αvβ3 signaling [30].”
BackgroundResultInfluentialTissue-resident versus monocyte-derived macrophages in the tumor microenvironment
Lahmar, Q., Keirsse, J., Laoui, D., Movahedi, K., Overmeire, E. V., & Ginderachter, J. A. V. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.06.009 · Cited by 173
Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance
Shi, Y., Guryanova, O. A., Zhou, W., Liu, C., Huang, Z., Fang, X., Wang, X., Chen, C., Wu, Q., He, Z., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aah6816 · Cited by 154
“GSCs promote therapeutic resistance, cancer invasion, tumor angiogenesis, immune evasion, and recruitment of tumor-supportive macrophages to facilitate malignant growth (2, 5, 6), indicating that targeting GSCs is an important strategy to improve GBM treatment.”
BackgroundDissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence
Aramini, B., Masciale, V., Grisendi, G., Bertolini, F., Maur, M., Guaitoli, G., Chrystel, I., Morandi, U., Stella, F., Dominici, M., et al. (2022) · Cancers · doi:10.3390/cancers14040976 · Cited by 145
Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies
Raggi, C., Mousa, H. S., Correnti, M., Sica, A., & Invernizzi, P. (2015) · Oncogene · doi:10.1038/onc.2015.132 · Cited by 159
Andersen, R. S., Anand, A., Harwood, D. S. L., & Kristensen, B. W. (2021) · Cancers · doi:10.3390/cancers13174255 · Cited by 159
“Periostin expression correlates with TAM density, and depletion of periostin in glioblastoma cells reduces TAM recruitment and inhibits tumor growth in mice bearing glioma stem-like cell-derived xenografts via integrin αvβ3 signaling [59].”
BackgroundDong, N., Shi, X., Wang, S., Gao, Y., Kuang, Z., Xie, Q., Li, Y., Deng, H., Wu, Y., Li, M., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0482-x · Cited by 140
Shui, L., Ren, H., Yang, X., Li, J., Chen, Z., Cheng, Y., Zhu, H., & Shui, P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.570465 · Cited by 173
“org 6 radiomic texture features and periostin expression levels, an important gene involved in GBM invasion and recurrence (65).”
BackgroundChen, C., Guo, Q., Liu, Y., Hou, Q., Liao, M., Guo, Y., Zang, Y., Wang, F., Liu, H., Luan, X., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1515 · Cited by 167
“69,71 We predicted the potential interaction of SPP1 + macrophages and POSTN + CAFs through NicheNet.”
BackgroundZheng, H., Liu, H., Li, H., Dou, W., Wang, J., Zhang, J., Liu, T., Wu, Y., Liu, Y., & Wang, X. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02913-0 · Cited by 160
“Recent studies showed that CSCs promoted the polarization of M2 macrophages and the recruitment of tumor-associated neutrophils (TANs), myeloid-derived suppressor cells (MDSCs) by inducing the abnormal expression of MHC-I molecules and the secretion of immunosuppressive cytokines, which were conducive to the formation…”
BackgroundLi, D., Zhang, Q., Li, L., Chen, K., Yang, J., Dixit, D., Gimple, R. C., Ci, S., Lu, C., Hu, L., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0507 · Cited by 147
Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy
Joshi, S., & Sharabi, A. B. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108114 · Cited by 154
“Emerging studies have shown that M-MDSCs can differentiate into M2-TAMs in the TME to promote tumor growth (Corzo et al., 2010; Qian et al., 2011; Zhou et al., 2015).”
BackgroundMolecular Mechanisms of Drug Resistance in Glioblastoma
Dymova, M. A., Kuligina, E. V., & Richter, V. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126385 · Cited by 152
“CSCs modulate T cell and tumor-associated microglia/macrophage function through secreted factors [81], which may be exploited in the development of vaccine strategies or of combinations with other drugs [82].”
BackgroundBrain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity
Gimple, R. C., Yang, K., Halbert, M. E., Agnihotri, S., & Rich, J. N. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00486-x · Cited by 155
miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy
Xi, J., Huang, Q., Wang, L., Ma, X., Deng, Q., Kumar, M., Zhou, Z., Li, L., Zeng, Z., Young, K. H., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0178-3 · Cited by 143
SOX2 in cancer stemness: tumor malignancy and therapeutic potentials
Mamun, M. M. A., Mannoor, K., Cao, J., Qadri, F., & Song, X. (2018) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy080 · Cited by 145
The key roles of cancer stem cell-derived extracellular vesicles
Su, C., Zhang, J., Yarden, Y., & Fu, L. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00499-2 · Cited by 148
“GSCs secrete a variety of cytokines and extracellular matrix components, such as periostin, colony-stimulating factor, TGF-β, and macrophage inhibitory cytokines, which drive the polarization of both tissueresident macrophages and recruited macrophages toward an M2 phenotype.(78,79) Consistently, ovarian CSCs also sec…”
BackgroundRaskov, H., Orhan, A., Gaggar, S., & Gögenür, I. (2022) · Oncogenesis · doi:10.1038/s41389-022-00398-3 · Cited by 146
Immune Checkpoint Targeted Therapy in Glioma: Status and Hopes
Qi, Y., Liu, B., Sun, Q., Xiong, X., & Chen, Q. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.578877 · Cited by 146
IL-10 secreted by M2 macrophage promoted tumorigenesis through interaction with JAK2 in glioma
Qi, L., Yu, H., Zhang, Y., Zhao, D., Lv, P., Zhong, Y., & Xu, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.12317 · Cited by 137
“The refractory glioma to standard therapies is regarded to spring from phenotypic heterogeneity and diffuse infiltration into normal brain parenchyma as well as residence within the unique immune environment of the central nervous system [3].”
InfluentialMack, S. C., Singh, I., Wang, X., Hirsch, R., Wu, Q., Villagomez, R., Bernatchez, J. A., Zhu, Z., Gimple, R. C., Kim, L. J. Y., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20190196 · Cited by 130
“NR2E1 (TLX) is an orphan nuclear hormone receptor previously implicated in both GSC and NSC renewal (Zhu et al., 2014).”
BackgroundDay, E. K., Sosale, N. G., & Lazzara, M. J. (2016) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2016.06.005 · Cited by 134
Wang, G., Zhong, K., Wang, Z., Zhang, Z., Tang, X., Tong, A., & Zhou, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.964898 · Cited by 162
Peng, P., Zhu, H., Liu, D., Chen, Z., Zhang, X., Guo, Z., Dong, M., Wan, L., Zhang, P., Liu, G., et al. (2022) · Theranostics · doi:10.7150/thno.69605 · Cited by 139
“To investigate whether M2-like TAMs-secreted TGFBI could induce the reversion of differentiated GSCs, we induced in vitro differentiation of GSCs by withdrawing growth factors and adding serum-containing medium (DMEM with 10% FBS) [32].”
BackgroundMethodImmunotherapies for malignant glioma
Boussiotis, V. A., & Charest, A. (2017) · Oncogene · doi:10.1038/s41388-017-0024-z · Cited by 137
Liu, D., Liang, S., Ma, K., Meng, Q., Li, X., Wei, J., Zhou, M., Yun, K., Pan, Y., Rao, L., et al. (2024) · Advanced Materials · doi:10.1002/adma.202304845 · Cited by 120
Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets
Codrici, E., Enciu, A., Popescu, I. D., Mihai, S., & Tănase, C. (2016) · Stem Cells International · doi:10.1155/2016/5728438 · Cited by 135
“In 2015, Zhou et al. provide new insights into where and how TAMs are recruited and educated by GSCs in GBMs [187].”
InfluentialCancer Stem Cells: Emerging Key Players in Immune Evasion of Cancers
Lei, M. M. L., & Lee, T. K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.692940 · Cited by 130
“The extracellular matrix protein periostin is preferentially expressed on CD133+CD15+ glioma CSCs and recruits macrophages through integrin αvβ3 from the peripheral blood to the brain (Zhou et al., 2015).”
BackgroundYu, B., Wu, K., Wang, X., Zhang, J., Wang, L., Jiang, Y., Zhu, X., Chen, W., & Yan, M. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-1116-6 · Cited by 121
RetractedRole of Microenvironment in Glioma Invasion: What We Learned from In Vitro Models
Manini, I., Caponnetto, F., Bartolini, A., Ius, T., Mariuzzi, L., Loreto, C. D., Beltrami, A. P., & Cesselli, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010147 · Cited by 139
Yang, Z., Liu, Y., Zhao, K., Jing, W., Gao, L., Dong, X., Wang, Y., Han, M., Shi, C., Tang, C., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.07.021 · Cited by 133
Periostin: biology and function in cancer
Dorafshan, S., Razmi, M., Safaei, S., Gentilin, E., Madjd, Z., & Ghods, R. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02714-8 · Cited by 131
NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma
Weiß, T., Schneider, H., Silginer, M., Steinle, A., Pruschy, M. N., Polić, B., Weller, M., & Roth, P. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1766 · Cited by 127
Zhong, L., Liao, D., Li, J., Liu, W., Wang, J., Zeng, C., Wang, X., Cao, Z., Zhang, R., Li, M., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00414-1 · Cited by 115
“In tumors, cancer cells generally promote the M2 phenotype macrophage polarization to remodel tumor microenvironment and to facilitate tumor progression.(39) For instance, the secreted LOX by tumor cells(40) or exosomal MIF(23) is able to create the favorable microenvironment in the distant organ for subsequent metast…”
BackgroundThe intersection of cancer, cancer stem cells, and the immune system: therapeutic opportunities
Silver, D. J., Sinyuk, M., Vogelbaum, M. A., Ahluwalia, M. S., & Lathia, J. D. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov157 · Cited by 126
Biology-guided deep learning predicts prognosis and cancer immunotherapy response
Jiang, Y., Zhang, Z., Wang, W., Huang, W., Chen, C., Xi, S., Ahmad, M. U., Ren, Y., Sang, S., Xie, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40890-x · Cited by 133
“On the other hand, periostin is an extracellular matrix protein secreted predominantly by stromal cells, which regulates cancer cell migration, invasion, metastatic dissemination, and chemoresistance 43 – 45 .”
Malric, L., Monferran, S., Gilhodes, J., Boyrie, S., Dahan, P., Skuli, N., Sesen, J., Filleron, T., Kowalski‐Chauvel, A., Moyal, E. C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20372 · Cited by 124
“M2 tumor-associated macrophages are recruited through association of their αvβ3 integrins with Periostin to favor tumor growth [134].”
BackgroundImmune modulation of hair follicle regeneration
Rahmani, W., Sinha, S., & Biernaskie, J. (2020) · npj Regenerative Medicine · doi:10.1038/s41536-020-0095-2 · Cited by 108
Distinct regional ontogeny and activation of tumor associated macrophages in human glioblastoma
Landry, A., Balas, M., Alli, S. B., Spears, J., & Zador, Z. E. (2020) · Scientific Reports · doi:10.1038/s41598-020-76657-3 · Cited by 122
Cancer Extracellular Matrix Proteins Regulate Tumour Immunity
Gordon-Weeks, A. N., & Yuzhalin, A. E. (2020) · Cancers · doi:10.3390/cancers12113331 · Cited by 132
Zheng, S., Huang, J.-L., Chen, M., Wang, B., Ou, Q., & Huang, S. (2017) · Journal of neurosurgery · doi:10.3171/2017.3.jns161648 · Cited by 111
Cancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic Strategies
Sainz, B., Carron, E., Vallespinós, M., & Machado, H. L. (2016) · Mediators of Inflammation · doi:10.1155/2016/9012369 · Cited by 110
“Deletion of periostin in glioma stem cells resulted in decreased M2 TAM density, reduced tumor growth, and consequently increased survival in glioblastoma xenografts [115].”
BackgroundLeblond, M. M., Pérès, E. A., Helaine, C., Gérault, A. N., Moulin, D., Anfray, C., Divoux, D., Petit, E., Bernaudin, M., & Valable, S. (2017) · Oncotarget · doi:10.18632/oncotarget.19994 · Cited by 110
“In accordance with this hypothesis, M2 MΦ are known to associate themselves with GSC in hypoxic areas [42, 43] to promote tumor development [44].”
BackgroundTumor-associated macrophages remodeling EMT and predicting survival in colorectal carcinoma
Li, S., Xu, F., Zhang, J., Wang, L., Zheng, Y., Wu, X., Wang, J., Huang, Q., & Lai, M. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1380765 · Cited by 109
“macrophages to promote tumor cell invasion and escape from killing by natural killer cells.(9) However, exploring the complex”
BackgroundZhai, K., Huang, Z., Huang, Q., Tao, W., Fang, X., Zhang, A., Li, X., Stark, G. R., Hamilton, T. A., & Bao, S. (2021) · Nature Cancer · doi:10.1038/s43018-021-00267-9 · Cited by 118
Ge, H., Mu, L., Jin, L., Yang, C., Chang, Y. E., Yu, L., DeLeon, G., Deleyrolle, L. P., Mitchell, D. A., Kubilis, P. S., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30830 · Cited by 114
Chen, Q., Han, B., Meng, X., Duan, C., Yang, C., Wu, Z., Magafurov, D., Zhao, S., Safin, S., Jiang, C., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32102 · Cited by 109
“In GBM, M2 could be recruited by periostin secreted by glioblastoma stem cells (GSC) to participate in malignant growth.(55) M2 macrophages produce TGF-β,(56) contributing to a tumour-supporting and immunosuppressive environment in tumours.”
BackgroundSa, J. K., Chang, N., Lee, H. W., Cho, H. J., Ceccarelli, M., Cerulo, L., Yin, J., Kim, S. S., Caruso, F. P., Lee, M., et al. (2020) · Genome biology · doi:10.1186/s13059-020-02140-x · Cited by 109
“quently promote GSC maintenance, therapeutic resistance, and tumor recurrence [22, 24, 41, 47].”
BackgroundZinn, P. O., Singh, S. K., Kotrotsou, A., Hassan, I., Thomas, G., Luedi, M. M., Elakkad, A., Elshafeey, N., Idris, T., Mosley, J., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3420 · Cited by 108
“POSTN, expressed in glioma cells including GSCs and secreted to extracellular matrix in tumormicroenvironment, is involved in invasion and perivascular niche formation, metastasis, and macrophage recruitment (19, 42).”
BackgroundValdor, R., García‐Bernal, D., Riquelme, D., Martínez, C. M., Moraleda, J. M., Cuervo, A. M., Macián, F., & Martínez, S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1903542116 · Cited by 115
Chen, Z., Xie, J., Hao, H., Lin, H., Wang, L., Zhang, Y., Chen, L. Y., Cao, S., Huang, X., Liao, W., et al. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx001 · Cited by 105
“52,53 Schwanekamp et al. showed that loss of periostin decreased macrophage recruitment to atherosclerotic lesions.”
BackgroundAstrocytes enhance glioblastoma growth
Mega, A., Nilsen, M. H., Leiss, L. W., Tobin, N. P., Miletić, H., Sleire, L., Strell, C., Nelander, S., Krona, C. C., Hägerstrand, D., et al. (2019) · Glia · doi:10.1002/glia.23718 · Cited by 103
“Selection of these genes was also based on previous studies implying these factors in GBM biology and linking them to shorter patient survival in the TCGA cohort (Park, Piao, Jeong, Dong, & de Groot, 2016; Roy et al., 2017; Zhou et al., 2015).”
BackgroundAn epigenetic gateway to brain tumor cell identity
Mack, S. C., Hubert, C. G., Miller, T. E., Taylor, M. D., & Rich, J. N. (2015) · Nature Neuroscience · doi:10.1038/nn.4190 · Cited by 109
Wang, Z., Xiong, S., Mao, Y., Chen, M., Ma, X., Zhou, X., Ma, Z., Liu, F., Huang, Z., Luo, Q., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4747 · Cited by 111
“A recent report shows that glioblastoma stem cell-derived POSTN recruits monocyte-derived M2 macrophages to accelerate malignant growth [46].”
BackgroundSeifert, G. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061628 · Cited by 110
“In turn, TAMs secrete growth factors that further stimulate cell division in GSCs generating a metastatic niche [105] (Figure 4B).”
BackgroundEiró, N., González, L. O., Fraile, M., Cid, S., Schneider, J., & Vizoso, F. J. (2019) · Cancers · doi:10.3390/cancers11050664 · Cited by 113
“by a dynamic integration of integrins with several extracellular factors, such as the ECM protein periostin [183], osteopontin-rich matrix [184], VCAM-1 [185,186] or fibronectin [185].”
BackgroundTumor‐associated macrophages in immunotherapy
Yan, S., & Wan, G. (2021) · FEBS Journal · doi:10.1111/febs.15726 · Cited by 112
Li, Z., Fu, W., Chen, X.-Q., Wang, S., Deng, R.-S., Tang, X., Yang, K., Niu, Q., Zhou, H., Li, Q., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02291-8 · Cited by 113
Cancer stem cells and niches: challenges in immunotherapy resistance
Pan, Y., Yuan, C., Zeng, C., Sun, C., Xia, L., Wang, G., Chen, X., Zhang, B., Liu, J., & Ding, Z. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02265-2 · Cited by 123
“Extrinsically, the remodeling of the CSC niche creates a favorable environment for immune evasion, such as recruiting immunosuppressive cells like Tregs and M2 macrophages, secreting cytokines like TGF-β, and creating metabolically hostile environments [87, 150, 151].”
Müller, S., Liu, S. J., Di Lullo, E., Malatesta, M., Pollen, A. A., Nowakowski, T. J., Kohanbash, G., Aghi, M., Kriegstein, A. R., Lim, D. A., et al. (2016) · Molecular Systems Biology · doi:10.15252/msb.20166969 · Cited by 101
Periostin: an emerging activator of multiple signaling pathways
Wang, Z., An, J., Zhu, D., Chen, H., Lin, A., Kang, J., Liu, W., & Kang, X. (2022) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-022-00674-2 · Cited by 111
“Many previous reports confirmed that POSTN is the upstream promoter of Wnt/β-catenin signaling in tumor-associated diseases (Zhang et al. 2017a; Zhou et al. 2015).”
Interactions between Tumor Cells, Neurons, and Microglia in the Glioma Microenvironment
Radin, D. P., & Tsirka, S. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228476 · Cited by 110
“Microglia can also promote stemness via the release of IL-6 [81,82], which may, in turn, induce glioma stem cells to recruit anti-inflammatory macrophages via periostin release [83].”
BackgroundZhang, X., Chen, Y., Hao, L., Hou, A., Chen, X., Li, Y., Wang, R., Luo, P., Ruan, Z., Ou, J., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.08.004 · Cited by 99
Bidirectional Crosstalk Between Cancer Stem Cells and Immune Cell Subsets
Müller, L., Tunger, A., Plesca, I., Wehner, R., Temme, A., Westphal, D., Meier, F. E., Bachmann, M. P., & Schmitz, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00140 · Cited by 104
“Periostin, a secreted extracellular matrix protein, produced by glioma stem cells was shown to attract M2 TAMs, promoting tumor growth (21).”
BackgroundAlleviating hypoxia to improve cancer immunotherapy
Fan, P., Zhang, N., Candi, E., Agostini, M., Piacentini, M., Bernassola, F., Bove, P., Alessandro, M., Giuseppe, N., Valentina, R., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02869-2 · Cited by 105
“In parallel, GSC-secreted factors attract immunosuppressive M2-like TAMs and upregulate the immunosuppressive function of MDSCs, further reinforcing the immunosuppressive microenvironment [121, 122].”
BackgroundBrain Cancer Stem Cells in Adults and Children: Cell Biology and Therapeutic Implications
Abouantoun, T. J., Hale, J. S., Lathia, J. D., & Dombrowski, S. M. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0524-0 · Cited by 108
Liu, H., Zhao, H., & Sun, Y. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.11.004 · Cited by 109
Chen, J., Liu, G., Wang, X., Hong, H., Li, T., Li, L., Wang, H., Xie, J., Li, B., Li, T., et al. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.09.009 · Cited by 107
Zalfa, C., & Paust, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.633205 · Cited by 107
“Several studies have shown the ability of M-MDSCs to differentiate into TAMs after migrating from the spleen to a tumor (178, 180, 182, 183), and TAMs can be “regenerated” by the arrival of newM-MDSCs from other organs during tumor progression (184–186) (Figure 1).”
BackgroundEngineering challenges for brain tumor immunotherapy
Lyon, J. G., Mokarram, N., Saxena, T. K., Carroll, S. L., & Bellamkonda, R. V. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.06.006 · Cited by 106
Chuang, H.-Y., Su, Y.-K., Liu, H.-W., Chen, C., Chiu, S., Cho, D., Lin, S., Chen, Y.-S., & Lin, C. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070959 · Cited by 103
“In addition, our observations were in agreement with previous studies, where interactions between GBM and GAMs increased CD133+ GSCs and malignant phenotypes [20,21].”
ResultLi, T., Li, K., Wang, C., Liu, X. Z., Wen, Y., Xu, Y., Zhang, Q., Zhao, Q.-Y., Shao, M., Li, Y.-Z., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.10.024 · Cited by 98
Ellert‐Miklaszewska, A., Wiśniewski, P., Kijewska, M., Gajdanowicz, P., Pszczolkowska, D., Przanowski, P., Dąbrowski, M., Maleszewska, M., & Kaminska, B. (2016) · Oncogene · doi:10.1038/onc.2016.55 · Cited by 101
Molecular and Microenvironmental Determinants of Glioma Stem-Like Cell Survival and Invasion
Roos, A., Ding, Z., Loftus, J. C., & Tran, N. L. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00120 · Cited by 113
“These peripheral monocytederived macrophages are recruited by GSCs to the microenvironment via a periostin/integrin αvβ3-dependent mechanism (95).”
BackgroundA molecular view of the radioresistance of gliomas
Han, X., Xue, X., Zhou, H., & Zhang, G. (2017) · Oncotarget · doi:10.18632/oncotarget.21753 · Cited by 105
Immunotherapy of Glioblastoma: Current Strategies and Challenges in Tumor Model Development
Majc, B., Novak, M., Kopitar‐Jerala, N., Jewett, A., & Breznik, B. (2021) · Cells · doi:10.3390/cells10020265 · Cited by 110
“Glioblastoma immunosuppressive TME is driven by tumor-intrinsic factors and brain (host) tissue responses to tumor antigens, such as overexpression of the indoleamine 2,3-dioxygenase (IDO) enzyme [54,55] and oncogene transforming growth factor-beta (TGF-β), respectively.”
BackgroundMicroglia and brain macrophages: An update
Sasaki, A. (2017) · Neuropathology · doi:10.1111/neup.12354 · Cited by 92
Galassi, C., Musella, M., Manduca, N., Maccafeo, E., & Sistigu, A. (2021) · Cells · doi:10.3390/cells10092361 · Cited by 101
Emerging Role of Glioma Stem Cells in Mechanisms of Therapy Resistance
Eckerdt, F., & Platanias, L. C. (2023) · Cancers · doi:10.3390/cancers15133458 · Cited by 110
Integrins in glioblastoma: Still an attractive target?
Paolillo, M., Serra, M., & Schinelli, S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.08.004 · Cited by 103
Yokota, K., Kobayakawa, K., Saito, T., Hara, M., Kijima, K., Ohkawa, Y., Harada, A., Okazaki, K., Ishihara, K., Yoshida, S., et al. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.11.010 · Cited by 101
“42 e 44 In this study, POSTN facilitated the in fi ltration of monocytes/macrophages into the injured spinal cord and promoted the expression of TNF-a derived from the in fi ltrating monocytes/macrophages.”
BackgroundSignaling pathways in the regulation of cancer stem cells and associated targeted therapy
Wang, M., & Wu, M. (2022) · MedComm · doi:10.1002/mco2.176 · Cited by 108
Huang, Q., Liu, L., Xiao, D., Huang, Z., Wang, W., Zhai, K., Fang, X., Kim, J., Liu, J. K., Liang, W., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.07.012 · Cited by 103
Yang, W., Yu, H., Shen, Y., Liu, Y., Yang, Z., & Sun, T. (2016) · Oncotarget · doi:10.18632/oncotarget.9214 · Cited by 93
Periostin Promotes Cell Proliferation and Macrophage Polarization to Drive Repair after AKI
Kormann, R., Kavvadas, P., Placier, S., Vandermeersch, S., Dorison, A., Dussaule, J., Chadjichristos, C. E., Prakoura, N., & Chatziantoniou, C. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019020113 · Cited by 89
Lin, C., Wang, N., & Xu, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1123853 · Cited by 112
“M2polarized microglia/macrophages are differentiated by the coexpression of surface markers such as CD163, CD204, CD206 as well as arginase (53).”
BackgroundMu, L., Long, Y., Yang, C., Jin, L., Tao, H., Ge, H., Chang, Y. E., Karachi, A., Kubilis, P. S., Leon, G. D., et al. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00082 · Cited by 93
“…regulatory T cells (Tregs), myeloid-derived suppressor cells (MDSCs), and tumorassociated macrophages (TAMs) (Almand et al., 2001; Dieckmann et al., 2001; Chen and Mellman, 2013; Zhou et al., 2015), may suppress antitumor immunity and play a critical role in cancer development and progression.”
BackgroundSaha, D., Martuza, R. L., & Rabkin, S. D. (2018) · Immunotherapy · doi:10.2217/imt-2018-0009 · Cited by 89
Schwanekamp, J. A., Lorts, A., Vagnozzi, R. J., Vanhoutte, D., & Molkentin, J. D. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306397 · Cited by 88
“A previous study showed that periostin can act as a chemoattractant for macrophages in a model of glioblastoma.(24) Indeed, similar to TGF-β, recombinant periostin protein caused a significant increase in the migration of WT macrophages but not Postn macrophages (Figure 6C).”
BackgroundValdor, R., García‐Bernal, D., Bueno, C., Rodenas, M., Moraleda, J. M., Macián, F., & Martínez, S. (2017) · Oncotarget · doi:10.18632/oncotarget.19804 · Cited by 97
Fang, X., Huang, Z., Zhai, K., Huang, Q., Tao, W., Kim, L. J. Y., Wu, Q., Almasan, A., Yu, J. S., Li, X., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abc7275 · Cited by 94
“Because GBM harbors tumorigenic GSCs that not only contribute to radioresistance (43) but also promote tumor angiogenesis (48), cancer invasion (49), recruitment of tumorassociated macrophages (50), and generation of vascular pericytes to form a blood-tumor barrier that blocks drug delivery (51, 52), the GSC populatio…”
BackgroundLipid-based nanosystems: the next generation of cancer immune therapy
Cheng, Z., Fobian, S., Gurrieri, E., Amin, M., D’Agostino, V., Falahati, M., Zalba, S., Debets, R., Garrido, M. J., Saeed, M., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01574-1 · Cited by 106
“Macrophages are recruited into the TME from the circulation [216, 217] and most become polarized towards the pro-tumor M2 phenotype, enhancing tumor cell proliferation, angiogenesis, neovascularization, metastasis, and immune suppression [218, 219].”
BackgroundThe role of periostin in neoplastic processes
Ratajczak‐Wielgomas, K., & Dzięgiel, P. (2015) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.a2015.0014 · Cited by 85
“macrophages (TAMs) by secreting POSTN [80]”
BackgroundShi, Y., Zhou, W., Cheng, L., Chen, C., Huang, Z., Fang, X., Wu, Q., He, Z., Xu, S., Lathia, J. D., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.110 · Cited by 91
“Orthotopic GBM xenografts were established through intracranial implantation of GBM cells as previous described.(8,42,48) Female C57BL/6 athymic/nude mice or NOG (NOD/Shiscid/IL-2Rgnull) immunocompromised mice of 4–6 weeks were purchased from Charles River Laboratories and were housed with no more than five animals pe…”
BackgroundMethodInfluentialMiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma
Liu, Y.-S., Lin, H.-Y., Lai, S.-W., Huang, C.-Y., Huang, B.-R., Chen, P.-Y., Wei, K.-C., & Lu, D.-Y. (2017) · Oncogene · doi:10.1038/onc.2017.129 · Cited by 86
Manta, C.-P., Leibing, T., Friedrich, M., Nolte, H., Adrian, M., Schledzewski, K., Krzistetzko, J., Kirkamm, C., David Schmid, C., Xi, Y., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.058615 · Cited by 84
Targeting Tumor Associated Macrophages to Overcome Conventional Treatment Resistance in Glioblastoma
Grégoire, H., Roncali, L., Rousseau, A., Chérel, M., Delneste, Y., Jeannin, P., Hindré, F., & Garcion, E. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00368 · Cited by 92
Won, W.-J., Deshane, J. S., Leavenworth, J. W., Oliva, C. R., & Griguer, C. E. (2019) · Cell Stress · doi:10.15698/cst2019.02.176 · Cited by 89
“tin secreted by GSC recruits M2-type glioma-associated macrophages (GAM) and promotes malignant growth [40].”
BackgroundZhang, T., Lip, H., He, C., Cai, P., Wang, Z., Henderson, J. T., Rauth, A. M., & Wu, X. Y. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201900543 · Cited by 81
Periostin: A Potential Therapeutic Target For Pulmonary Hypertension?
Nie, X., Shen, C., Tan, J., Wu, Z., Wang, W., Chen, Y., Dai, Y., Yang, X., Ye, S., Chen, J., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.316943 · Cited by 87
Metadata
- Authors
- Zhou, W., Ke, S. Q., Huang, Z., Flavahan, W., Fang, X., Paul, J., Wu, L., Sloan, A. E., McLendon, R. E., Li, X., Rich, J. N., & Bao, S.
- Affiliations
- Cleveland Clinic (US)
- University Hospitals Cleveland Medical Center (US)
- Duke Medical Center (US)
- Corresponding author
- Bao, Shideng
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2015-01-12
- Volume
- 17
- Issue
- 2
- Pages
- 170-182
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC4312504
- OpenAlex
- W2073586533
- Cited by
- 940
- References
- 67
- Citations by year
- 2026: 29 · 2025: 74 · 2024: 93 · 2023: 101 · 2022: 118 · 2021: 117 · 2020: 93 · 2019: 82 · 2018: 71 · 2017: 81 · 2016: 50 · 2015: 30
- FWCI
- 38.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Cleveland Clinic
- National Institutes of Health (1r01ns071996-01a1)
- National Institute of General Medical Sciences (T32GM007250)
- National Institute of Allergy and Infectious Diseases (T32AI089474)
- National Institute of Neurological Disorders and Stroke (R01-NS071996, R01NS070315)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- periostin, glioblastoma, glioma stem cells, tumour-associated macrophages, M2 macrophages, macrophage recruitment, integrin αvβ3, RGD peptide, monocyte-derived macrophages, tumor microenvironment, tumor growth, therapeutic target
- MeSH terms
- Animals, Brain Neoplasms, Cell Count, Chemotactic Factors, Female, Fluorescent Antibody Technique, Glioblastoma, Humans, Luminescent Measurements, Macrophages, Mice, Inbred C57BL, Monocytes, Neoplastic Stem Cells, Signal Transduction, Cell Adhesion Molecules, Survival Analysis, Gene Silencing, Xenograft Model Antitumor Assays, RNA, Small Interfering, Integrin alphaVbeta3, Cell Line, Tumor, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.